Drugs / Piritramide
Piritramide
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT00188227 | Sep 2001 → Nov 2003 | — | Technical University Dresden | Completed | No outcome recorded |
| Phase not applicable1 trial · 1 met primary | ||||||
| — | NCT05831761 | Sep 2009 → Oct 2011 | — | University Medical Centre Ljubljana | Completed | Met primary |
| Comparator or background therapy9 trials | ||||||
| Phase 3 | NCT00547989 Comparator | Oct 2006 → Dec 2010 | breast cancer | Maastricht University Medical Center | Completed | No outcome recorded |
| Phase 4 | NCT03700541 Comparator | Jan 2019 → Nov 2023 | colorectal cancer | The Institute of Molecular and Translational Medicine, Czech Republic | Completed | No outcome recorded |
| Phase 4 | NCT03700411 Comparator | Jan 2019 → Nov 2023 | colorectal cancer | The Institute of Molecular and Translational Medicine, Czech Republic | Completed | No outcome recorded |
| Phase 4 | NCT03541759 Comparator | Jan → May 2018 | — | AUVA Traumazentrum Vienna Site UKH Meidling | Completed | No outcome recorded |
| Phase 4 | NCT02314871 Comparator | Jan 2015 → Mar 2019 | colon carcinoma | The Institute of Molecular and Translational Medicine, Czech Republic | Completed | No outcome recorded |
| Phase 4 | NCT02544282 Comparator | Apr 2014 → Mar 2016 | — | GZA Ziekenhuizen Campus Sint-Augustinus | Completed | No outcome recorded |
| Phase 4 | NCT01115101 Comparator | Jul → Nov 2009 | — | Max Dieterich | Completed | No outcome recorded |
| — | NCT04699422 Comparator | Dec 2020 → Jul 2022 | heart disorder | Jessa Hospital | Completed | No outcome recorded |
| — | NCT03079830 Comparator | Oct 2016 → Dec 2017 | aortic valve disorder | University Medical Centre Ljubljana | Completed | No outcome recorded |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 12 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | piritramide | “Postoperative intravenous infusion of piritramid patient controlled analgesia (PCA) (piritramide 0.5 mg/ml; infusion 1,5 mg/h, bolus 1,5 mg, lock out 30 minutes)” NCT05831761 ↗5“Local infiltration with bupivacaine and Piritramide and Paracetamol as postoperative analgesic, and ondansetron as required” NCT00547989 ↗ |
| Known as | Dipidolor | “with piritramide (Dipidolor®, Janssen)” NCT04699422 ↗ |
| Known as | IDS-NP-013 | ChEMBL registry synonym — accepted as the source's own label CHEMBL559288 ↗ |
| Known as | piritramid | “Postoperative intravenous infusion of piritramid patient controlled analgesia (PCA) (piritramide 0.5 mg/ml; infusion 1,5 mg/h, bolus 1,5 mg, lock out 30 minutes)” NCT05831761 ↗ |
| Known as | Piritramida | ChEMBL registry synonym — accepted as the source's own label CHEMBL559288 ↗ |
| Known as | R 3365 | ChEMBL registry synonym — accepted as the source's own label CHEMBL559288 ↗ |
| Modality | Small molecule | — CHEMBL559288 ↗ |
| Route | Intramuscular | “Piritramide 0.2 mg/kg i.m.” NCT00547989 ↗ |